Chronotherapy for Hypertension

Research output: Contribution to journalReview articlepeer-review

77 Scopus citations


Purpose of Review: Given the emerging knowledge that circadian rhythmicity exists in every cell and all organ systems, there is increasing interest in the possible benefits of chronotherapy for many diseases. There is a well-documented 24-h pattern of blood pressure with a morning surge that may contribute to the observed morning increase in adverse cardiovascular events. Historically, antihypertensive therapy involves morning doses, usually aimed at reducing daytime blood pressure surges, but an absence of nocturnal dipping blood pressure is also associated with increased cardiovascular risk. Recent Findings: To more effectively reduce nocturnal blood pressure and still counteract the morning surge in blood pressure, a number of studies have examined moving one or more antihypertensives from morning to bedtime dosing. More recently, such studies of chronotherapy have studied comorbid populations including obstructive sleep apnea, chronic kidney disease, or diabetes. Summary: Here, we summarize major findings from recent research in this area (2013–2017). In general, nighttime administration of antihypertensives improved overall 24-h blood pressure profiles regardless of disease comorbidity. However, inconsistencies between studies suggest a need for more prospective randomized controlled trials with sufficient statistical power. In addition, experimental studies to ascertain mechanisms by which chronotherapy is beneficial could aid drug design and guidelines for timed administration.

Original languageEnglish (US)
Article number97
JournalCurrent Hypertension Reports
Issue number11
StatePublished - Nov 1 2018


  • Blood pressure
  • Chronotherapy
  • Circadian rhythms
  • Hypertension
  • Non-dipping
  • Sleep

ASJC Scopus subject areas

  • Internal Medicine


Dive into the research topics of 'Chronotherapy for Hypertension'. Together they form a unique fingerprint.

Cite this